FIELD: medicine, ophthalmology. SUBSTANCE: invention relates to the preparation thymolol from the group of noncardioselective β-adrenoblocking agents that is used for intraocular pressure decrease and glaucoma treatment. Method involves the use of thymolol in combination with compounds enhancing its capability to decrease intraocular pressure, in part, hyaluronic acid. Thymolol and hyaluronic acid were taken at mass ratio = 1:(2-4). Concentration of solution containing this combination is 0.01-0.05%. EFFECT: decreased thymolol dose, prolonged effect of agent. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREPARING PROLONGED-ACTION EYE DROPS MADE OF PILOCARPINE HYDROCHLORIDE | 1993 |
|
RU2106137C1 |
PHARMACEUTICAL COMPOSITION IN FORM OF GEL-LIKE OPHTHALMIC DROPS FOR TREATING GLAUCOMA | 2015 |
|
RU2576778C1 |
ANTIGLAUCOMATOUS AGENT | 1997 |
|
RU2128486C1 |
COMPOSITION FOR INTEGRATED TREATMENT OF PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA AND OCULAR SURFACE DISEASES | 2013 |
|
RU2517033C1 |
ANTIGLAUCOMATOUS PREPARATION | 2000 |
|
RU2191013C2 |
METHOD OF PARASITE ABOLISHMENT CAUSING DISEASE IN AQUARIUM FISHES | 1994 |
|
RU2060655C1 |
METHOD OF UROKINASE STABILITY INCREASE TO HEATING | 1993 |
|
RU2061043C1 |
METHOD FOR PROLONGING THE NEEDLING RESULTS OF THE SCAR-MODIFIED FILTRATION PAD | 2019 |
|
RU2734050C1 |
METHOD OF PREPARING PREPARATION PREVENTING EARLY EJACULATION | 1993 |
|
RU2074712C1 |
COMPOSITION FOR BATH | 1994 |
|
RU2077317C1 |
Authors
Dates
1997-09-10—Published
1994-01-28—Filed